股票行情快报:心脉医疗(688016)12月8日主力资金净买入319.21万元

Core Viewpoint - The stock of Xinmai Medical (688016) has shown a slight decline, with recent trading data indicating mixed capital flows among different investor categories, highlighting potential volatility in investor sentiment [1][2]. Group 1: Stock Performance - As of December 8, 2025, Xinmai Medical closed at 93.1 yuan, down 0.09% with a turnover rate of 0.72% and a trading volume of 8,897 lots, amounting to a total transaction value of 83.06 million yuan [1]. - Over the past five days, the stock has experienced fluctuations, with a notable increase of 1.28% on December 5, followed by a decline on subsequent days [2]. Group 2: Capital Flows - On December 8, 2025, the net inflow of main funds was 3.19 million yuan, accounting for 3.84% of the total transaction value, while retail investors saw a net outflow of 6.99 million yuan, representing 8.41% of the total [1][2]. - The recent five-day capital flow data indicates a trend of net outflows from retail investors, contrasting with net inflows from institutional and speculative funds on certain days [2]. Group 3: Financial Metrics and Industry Comparison - Xinmai Medical's total market capitalization is 11.476 billion yuan, with a net asset value of 3.982 billion yuan and a net profit of 429 million yuan, ranking 16th in the medical device industry [3]. - The company reported a gross margin of 70.4% and a net margin of 41.69%, significantly outperforming industry averages, with a price-to-earnings ratio of 20.06 compared to the industry average of 65.06 [3]. - For the first three quarters of 2025, Xinmai Medical's main revenue was 1.015 billion yuan, a year-on-year increase of 4.66%, while the net profit decreased by 22.46% [3]. Group 4: Analyst Ratings - In the last 90 days, nine institutions have provided ratings for Xinmai Medical, with seven recommending a buy and two suggesting an increase in holdings, indicating a generally positive outlook [4]. - The average target price set by institutions over the past 90 days is 136.03 yuan, suggesting potential upside from the current trading price [4].

Endovastec-股票行情快报:心脉医疗(688016)12月8日主力资金净买入319.21万元 - Reportify